22 results
8-K
EX-99.1
NGNE
Neurogene Inc
22 Apr 24
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
4:44pm
at this link https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=59597.
About Neurogene
The mission of Neurogene is to treat devastating
8-K
EX-99.1
NGNE
Neurogene Inc
18 Mar 24
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
4:10pm
on Wednesday, March 20 at 9:30 a.m. ET
About Neurogene
The mission of Neurogene is to treat devastating neurological diseases to improve the lives
8-K
EX-99.1
NGNE
Neurogene Inc
4 Mar 24
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett
7:30am
evidence of a potentially compelling efficacy and safety profile in Rett syndrome.
About Neurogene
Neurogene’s mission is to treat devastating
8-K
EX-99.1
mxvyrqx6if7die
5 Jan 24
Neurogene Announces Business Update and 2024 Outlook
7:11am
8-K
EX-10.6
478u9szctmy
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-99.2
mslwt
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-99.1
pzt5wbllao3si8ybk7z
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
425
ie7 qsg6yt
4 Dec 23
Business combination disclosure
5:14pm
8-K
EX-10.1
mckahkcix8zj6keg
4 Dec 23
Other Events
5:10pm
425
m7nlclo0z25ms
30 Nov 23
Business combination disclosure
4:06pm
S-4/A
cdudgk 6rds
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4
zo0k6yx1khyyy22y
18 Aug 23
Registration of securities issued in business combination transactions
6:19pm
425
z243 mb4m
18 Jul 23
Business combination disclosure
4:02pm
425
iwlko7lvi4pxdfkbl7v2
18 Jul 23
Business combination disclosure
8:37am
8-K
EX-99.1
iexpodsqs8 ldkgretor
18 Jul 23
Neurogene and Neoleukin Announce Definitive Merger Agreement
8:34am
8-K
EX-2.1
581yfpe4p0x2ynkld8zf
18 Jul 23
Neurogene and Neoleukin Announce Definitive Merger Agreement
8:34am